Indiana GLP-1 Law Update and What It Means | GLP Winner | GLP Winner

There has been a lot of conversation lately about new laws that could affect compounded GLP-1 medications. If you are new to this topic, you are not alone. These bills can sound technical, but the big picture is about how states and the federal government decide who can compound medications, how they do it, and what rules they must follow.

Here is where things stand right now in Indiana, Florida, and Washington.

Indiana Bill Amended: A Softer Version Moves Forward

Indiana Senate Bill 282, often called SB 282, originally raised major concerns because earlier drafts included strict new rules that could have made compounding much harder in the state.

That changed.

In a recent update, Sabina Hemmi shared that the bill was amended and that “a lot of the compounding stuff has been torn out” and that it is now “much less of an existential threat to compounding access for people who are in Indiana” (YouTube).

Official legislative records show SB 282 was amended and continues moving through the Indiana General Assembly with a narrower focus and without many of the earlier compounding specific restrictions (Indiana General Assembly).

Instead of creating an entirely new state compounding system, the revised bill largely leans on existing federal rules under the Food, Drug, and Cosmetic Act, which compounding pharmacies already have to follow (Indiana General Assembly).

There are still some requirements tied to documentation for API manufacturers and new oversight for medical spas, including registration and adverse event reporting. Parts of that medical spa oversight are not scheduled to begin until January 2027 (Indiana General Assembly).

In simple terms, the bill is still active, but it is no longer the broad compounding crackdown that many feared earlier.

Florida Bills Still Under Review

Florida lawmakers are considering their own legislation aimed at compounded medications marketed for weight loss, including GLP-1 based products.

Florida Senate Bill 860 would define “compounded medication” in state law and restrict the sale or distribution of compounded weight loss drugs unless specific sourcing and documentation requirements are met (Florida Senate).

A related House bill, HB 877, is also moving through the committee process (Florida Senate).

Legal analysis of SB 860 explains that it would require APIs (active pharmaceutical ingredients) to be pharmaceutical grade, come from FDA registered and recently inspected facilities, and be backed by testing and documentation before products could be distributed (Florida Healthcare Law Firm Analysis).

Right now in Florida, these bills have not passed. They are still in committees, which means they can still be changed, delayed, or stopped.

Federal SAFE Drugs Act Still in Committee

At the national level, lawmakers introduced the Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025, also called H.R. 6509.

This proposal would change parts of the Federal Food, Drug, and Cosmetic Act to expand how the government defines compounded drugs that are “essentially a copy” of FDA approved medications. It would also add reporting and oversight requirements for certain compounding activities (Congress.gov).

The bill was introduced by Representatives Rudy Yakym and André Carson, who said the goal is to strengthen patient safety and oversight of compounded drugs (Press Release).

Federal status is that the bill has been referred to the House Energy and Commerce Committee and has not yet been passed by Congress (Congress.gov).

What This Means for You

If you are a patient, caregiver, or provider, here is the big takeaway.

Rules around compounded GLP-1 medications are getting more attention from lawmakers. That does not automatically mean access will disappear, but it does mean there may be more paperwork, more oversight, and more variation between states depending on how these bills evolve.

In Indiana, the most severe restrictions were pulled back, which many see as a positive shift. In Florida, proposals are still early and could still change. At the federal level, broader changes are being discussed but have not become law.

This is a moving target. Laws can change language several times before final votes, and public feedback can influence that process.

What You Can Do Now

If this topic affects you, your voice still matters.

You can contact your state and federal representatives to share your perspective on access, safety, and how these policies affect real patients and providers. Lawmakers often track how many people reach out on a specific issue, and personal stories can carry weight during committee discussions and amendments.

You can also follow official bill pages to track status updates as votes, amendments, and hearings are scheduled. Legislative processes can feel slow, but many important changes happen quietly at the committee level before the public hears about them.

Staying informed and speaking up early gives you a better chance of being heard while these decisions are still being shaped.

How to Find Your Representatives

If you want to share your thoughts about these bills, the first step is knowing who represents you. You have state representatives, who vote on state laws like the Indiana or Florida bills, and federal representatives, who vote on laws in Congress.

To find your U.S. House Representative, enter your ZIP code on the official House website (U.S. House of Representatives).

To find your U.S. Senators, select your state on the official Senate website (U.S. Senate).

For state level bills, search online for “find my legislator” plus your state name - Google is great for this. Most states have an official lookup tool where you enter your address. For example, Indiana residents can use the Indiana General Assembly site and Florida residents can use the Florida Legislature’s tool.

When you contact an office, keep it simple. Say you are a constituent, mention the legislation you are following, explain how access to compounded medications affects you or your community, and thank them for their time. Calls and emails are both tracked, and even short messages are counted.

If you enjoy posts like these, you can subscribe to receive newsletter updates.